BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
$393M |
| 3 |
Microsoft
MSFT
|
$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.26B |
| 2 |
Salesforce
CRM
|
$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$368M |
| 4 |
Eli Lilly
LLY
|
$255M |
| 5 |
AGN
Allergan plc
AGN
|
$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Thermo Fisher Scientific
TMO
$186B
| $44.8M | 0.08% |
123,777
+31,142
| +34% | +$11.3M |
|
152
General Dynamics
GD
$86.8B
| $44.1M | 0.08% |
294,872
+187,332
| +174% | +$28M |
|
153
Regeneron Pharmaceuticals
REGN
$60.8B
| $43.9M | 0.08% |
70,447
-5,172
| -7% | -$3.23M |
|
154
KLA
KLAC
$119B
| $43.9M | 0.08% |
225,737
+85,268
| +61% | +$16.6M |
|
155
Boston Properties
BXP
$12.2B
| $43.2M | 0.08% |
477,673
+356,516
| +294% | +$32.2M |
|
156
Union Pacific
UNP
$131B
| $43.1M | 0.08% |
254,958
+44,776
| +21% | +$7.57M |
|
157
Vanguard S&P 500 ETF
VOO
$728B
| $42.6M | 0.08% |
150,395
+139,015
| +1,222% | +$39.4M |
|
158
Dollar General
DG
$24.1B
| $42.4M | 0.07% |
222,403
+23,625
| +12% | +$4.5M |
|
159
Crown Castle
CCI
$41.9B
| $42.3M | 0.07% |
252,912
+136,076
| +116% | +$22.8M |
|
160
Motorola Solutions
MSI
$79.8B
| $42.2M | 0.07% |
301,315
-698,180
| -70% | -$97.8M |
|
161
Herbalife
HLF
$1.02B
| $42M | 0.07% |
933,432
+487,063
| +109% | +$21.9M |
|
162
Stryker
SYK
$150B
| $41.9M | 0.07% |
232,616
+105,735
| +83% | +$19.1M |
|
163
Walmart
WMT
$801B
| $41.7M | 0.07% |
1,045,581
+69,000
| +7% | +$2.75M |
|
164
US Bancorp
USB
$75.9B
| $41.3M | 0.07% |
1,122,818
+299,302
| +36% | +$11M |
|
165
Marsh & McLennan
MMC
$100B
| $41.2M | 0.07% |
383,466
+125,553
| +49% | +$13.5M |
|
166
Agilent Technologies
A
$36.5B
| $40.6M | 0.07% |
459,955
+33,076
| +8% | +$2.92M |
|
167
Medtronic
MDT
$119B
| $40.5M | 0.07% |
441,427
-389,156
| -47% | -$35.7M |
|
168
Intuitive Surgical
ISRG
$167B
| $40.4M | 0.07% |
212,667
+1,161
| +0.5% | +$221K |
|
|
MXIM
169
DELISTED
Maxim Integrated Products
MXIM
| $40.3M | 0.07% |
665,581
+462,684
| +228% | +$28M |
|
170
Prologis
PLD
$105B
| $40.2M | 0.07% |
431,026
-245,304
| -36% | -$22.9M |
|
171
PNC Financial Services
PNC
$80.5B
| $39.9M | 0.07% |
379,587
+177,740
| +88% | +$18.7M |
|
172
iShares Core US Aggregate Bond ETF
AGG
$131B
| $39.6M | 0.07% |
335,338
+289,060
| +625% | +$34.2M |
|
173
Autodesk
ADSK
$69.5B
| $39.5M | 0.07% |
165,005
+71,466
| +76% | +$17.1M |
|
|
RSX
174
DELISTED
VanEck Russia ETF
RSX
| $39.4M | 0.07% |
1,901,059
+574,685
| +43% | +$11.9M |
|
175
Monster Beverage
MNST
$61B
| $39.3M | 0.07% |
1,135,236
+278,186
| +32% | +$9.64M |
|